Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ARTL Artelo Biosciences Inc

1,3261

0,0361 (2,80%)

09 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Artelo Biosciences (NASDAQ:ARTL)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Artelo Biosciences Charts.

Artelo Biosciences (NASDAQ:ARTL)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Artelo Biosciences Charts.

News Artelo Biosciences Inc

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Dienstag 23 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
Montag 22 April 2024 (2 Wochen vor) • GlobeNewswire Inc.

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Montag 25 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Dienstag 12 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
Dienstag 23 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
Montag 8 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Dienstag 5 Dezember 2023 (5 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Donnerstag 30 November 2023 (5 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Montag 13 November 2023 (6 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
Donnerstag 9 November 2023 (6 Monate vor) • GlobeNewswire Inc.

Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023
Donnerstag 2 November 2023 (6 Monate vor) • GlobeNewswire Inc.

Weitere Artelo Biosciences Inc News-Artikel

Energy Select Sector SPDR

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen